Anavex Life Sciences Corp (AVXL)

[Investor2014]

Perhaps I was being a little too excited with my "it works" exclamation. What the abstract says though is that in the lab A2-73 did indeed do what they were hoping and expecting.

We do not know if A2-73 will halt the progression or even partly or fully reverse MS. For that we need clinical trials.

I would say the implication at this point is that clinical trials in MS will be initiated by someone. Will that someone by Biogen or as I suggested in another post Teva, Celgene, Anavex or some other partner, I do not know.